Does proteasome inhibition play a role in mediating neuropathology and neuron death in Alzheimer's disease?

Journal of Alzheimer's Disease

Volumn 5, Issue 3, 2003, Pages 241-245

  Ding, Qunxing ^a   Keller, Jeffrey N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Neuron; Oxidative stress; Proteasome; Protein aggregation; Protein oxidation; Ubiquitin

Indexed keywords

PROTEASOME;

ALZHEIMER DISEASE; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL NECROSIS; NEUROPATHOLOGY; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUESTIONNAIRE;

EID: 0142074304     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2003-5307     Document Type: Article

References (46)

1. W. Baumeister, J. Walz, F. Zhul and E. Seemuller, The proteasome: paradigm of a self-compartmentalizing protease, Cell 92 (1998), 367-380.
2. N.F. Bence, R.M. Sampat and R.R. Kopito, Impairment of the ubiquitin-proteasome system by protein aggregation, Science 292 (2001), 1552-1555.
3. E.F. Blommaart, J.J. Luiken and A.J. Meijer, Autophagic proteolysis: control and specificity, Histochem. J. 29 (1997), 365-385.
4. D.A. Butterfield and J. Kanski, Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins, Mech. Ageing Dev. 122 (2001), 945-962.
5. O. Coux, K. Tanaka and A.L. Goldberg, Structure and functions of the 20S and 26S proteasomes, Annu. Rev. Biochem. 65 (1996), 801-847.
6. F.M. De Vrij, J.A. Sluijs, L. Gregori, D.F. Fischer, W.T. Hermens, D. Goldgaber, J. Verhaagen, F.W. Van Leeuwen and E.M. Hol, Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death, FASEB J. 15 (2001), 2680-2688.
7. Q. Ding and J.N. Keller, Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins, J. Neurochem. 77 (2001), 1010-1017.
8. Q. Ding and J.N. Keller, Proteasomes and proteasome inhibition in the central nervous system, Free Radic. Biol. Med. 31 (2001), 574-584.
9. Q. Ding, J.J. Lewis, K.M. Strum, E. Dimayuga, A.J. Bruce-Keller, J.C. Dunn and J.N. Keller, Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival, J. Biol. Chem. 277 (2002), 13935-13942.
10. B. Friguet and L.I. Szweda, Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein, FEBS Lett. 405 (1997), 21-25.
11. B. Friguet, E.R. Stadtman and L.I. Szweda, Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease, J. Biol. Chem. 269 (1994), 21639-21643.
12. S. Glockzin, A. von Knethen, M. Scheffner and B. Brune, Activation of the cell death program by nitric oxide involves inhibition of the proteasome, J. Biol. Chem. 274 (1999), 19581-19586.
13. A.L. Goldberg, T.N. Akopian, A.F. Kisselev, D.H. Lee and M. Rohrwild, New insights into the mechanisms and importance of the proteasome in intracellular protein degradation, Biol. Chem. 378 (1997), 131-140.
14. M. Groettrup, S. Khan, K. Schwarz and G. Schmidtke, Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 83 (2001), 367-372.
15. M. Groettrup, M. van den Broek, K. Schwarz, A. Macagno, S. Khan, R. de Giuli and G. Schmidtke, Structural plasticity of the proteasome and its function in antigen processing, Crit. Rev. Immunol. 21 (2001), 339-358.
16. T. Grune, Oxidative stress, aging and the proteasomal system, Biogerontology 1 (2000), 31-40.
17. D.H. Hyun, M.H. Lee, B. Halliwell and P. Jenner, Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration? J. Neurochem. 83 (2002), 360-370.
18. J.N. Keller, K.B. Hanni and W.R. Markesbery, Impaired proteasome function in Alzheimer's disease, J. Neurochem. 75 (2000), 436-439.
19. J.N. Keller and W.R. Markesbery, Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death, J. Neurosci. Res. 61 (2000), 436-442.
20. R.R. Kopito, Aggresomes, inclusion bodies and protein aggregation, Trends Cell Biol. 10 (2000), 524-530.
21. Y.A. Lam, C.M. Pickart, A. Alban, M. Landon, C. Jamieson, R. Ramage, R.J. Mayer and R. Layfield, Inhibition of the ubiquitin-proteasome system in Alzheimer's disease, Proc. Natl. Acad. Sci. USA 97 (2000), 9902-9906.
22. F.W. Leeuwen, J.P. Burbach and E.M. Hol, Mutations in RNA: a first example of molecular misreading in Alzheimer's disease, Trends Neurosci. 21 (1998), 331-335.
23. M. Lopez Salon, L. Morelli, E.M. Castano, E.F. Soto and J.M. Pasquini, Defective ubiquitination of cerebral proteins in Alzheimer's disease, J. Neurosci. Res. 62 (2000), 302-310.
24. K.S. McNaught, R. Belizaire, P. Jenner, C.W. Olanow and O. Isacson, Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease, Neurosci. Lett. 326 (2002), 155-158.
25. K.S. McNaught, L.M. Bjorklund, R. Belizaire, O. Isacson, P. Jenner and C.W. Olanow, Proteasome inhibition causes nigral degeneration with inclusion bodies in rats, Neuroreport 13 (2002), 1437-1441.
26. K.S. McNaught, R. Belizaire, O. Isacson, P. Jenner and C.W. Olanow, Altered proteasomal function in sporadic Parkinson's disease, Exp. Neurol. 179 (2003), 38-46.
27. K. Okada, C. Wangpoengtrakul, T. Osawa, S. Toyokuni, K. Tanaka and K. Uchida, 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules, J. Biol. Chem. 274 (1999), 23787-23793
28. M.A. Pappolla, M. Sos, R.A. Omar and K. Sambamurti, The heat shock/oxidative stress connection. Relevance to Alzheimer disease, Mol. Chem. Neuropathol. 28 (1996), 21-34.
29. L.A. Pasquini, M. Besio-Moreno, A.M. Adamo, J.M. Pasquini and E.F. Soto, Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells, J. Neurosci. Res. 59 (2000), 601-611.
30. C.S. Pillay, E. Elliott and C. Dennison, Endolysosomal proteolysis and its regulation, Biochem. J. 363 (2002), 417-429.
31. C. Porcile, P. Piccioli, S. Stanzione, A. Bajetto, R. Bonavia, S. Barbero, T. Florio and G. Schettinia, Proteasome inhibitors induce cerebellar granule cell death: inhibition of nuclear factor-kB activation, Ann. N.Y. Acad. Sci. 973 (2002), 402-413.
32. J.H. Qiu, A. Asai, S. Chi, N. Saito, H. Hamada and T. Kirino, Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons, J. Neurosci. 20 (2000), 259-265,
33. T. Reinheckel, N. Sitte, O. Ullrich, U. Kuckelkorn, K.J. Davies and T. Grune, Comparative resistance of the 20S and 26S proteasome to oxidative stress, Biochem. J. 335 (1998), 637-642.
34. C. Reiss, T. Lesnik, H. Parvez, S. Parvez and R. Ehrlich, Conformational toxicity and sporadic conformational diseases, Toxicology 153 (2002), 115-121.
35. H.J. Rideout and L. Stefanis, Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination, Mol. Cell. Neurosci. 21 (2002), 223-238.
36. H.J. Rideout, Q. Wang, D.S. Park and L. Stefanis, Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition, J. Neurosci. 23 (2003), 1237-1245.
37. K.L. Rock and A.L. Goldberg, Degradation of cell proteins and the generation of MHC class 1-presented peptides, Ann Rev Immunol 17 (1999), 739-779.
38. L.M. Sayre, M.A. Smith and G. Perry, Chemistry and biochemistry of oxidative stress in neurodegenerative disease, Curr. Med. Chem. 8 (2001), 721-738
39. R. Shringarpure, T. Grune, N. Sitte and K.J. Davies, 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease, Cell. Mol. Life Sci. 57 (2000), 1802-1809.
40. C. Soti and P. Csermely, Chaperones and aging: role in neurodegeneration and in other civilizational diseases, Neurochem. Int. 41 (2002), 383-389.
41. G. Taglialatela, J.A. Kaufmann, A. Trevino and J.R. Perez-Polo, Central nervous system DNA fragmentation induced by the inhibition of nuclear factor kappa B, Neuroreport 9 (1998), 489-493.
42. K. Tanaka, Proteasomes: structure and biology, J. Biochem. (Tokyo) 123 (1998), 195-204.
43. J.P. Taylor, F. Tanaka, J. Robitschek, C.M. Sandoval, A. Taye, S. Markovic-Plese and K.H. Fischbeck, Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein, Hum. Mol. Genet. 12 (2003), 749-757.
44. S. Varadarajan, S. Yatin, M. Aksenova and D.A. Butterfield, Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity, J. Struct. Biol. 130 (2000), 184-208.
45. W.R. Markesbery, Oxidative stress hypothesis in Alzheimer's disease, Free Radic. Biol. Med. 23 (1997), 134-147.
46. W.R. Markesbery and J.M. Carney, Oxidative alterations in Alzheimer's disease, Brain Pathol. 9 (1999), 133-146.